CN114634946B - Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide - Google Patents

Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide Download PDF

Info

Publication number
CN114634946B
CN114634946B CN202210181077.8A CN202210181077A CN114634946B CN 114634946 B CN114634946 B CN 114634946B CN 202210181077 A CN202210181077 A CN 202210181077A CN 114634946 B CN114634946 B CN 114634946B
Authority
CN
China
Prior art keywords
leu
ala
ser
gly
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210181077.8A
Other languages
Chinese (zh)
Other versions
CN114634946A (en
Inventor
王昕�
郭元柯
王静
马琛
陈可泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN202210181077.8A priority Critical patent/CN114634946B/en
Publication of CN114634946A publication Critical patent/CN114634946A/en
Application granted granted Critical
Publication of CN114634946B publication Critical patent/CN114634946B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01002Formate dehydrogenase (1.2.1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01046Formaldehyde dehydrogenase (1.2.1.46)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y603/00Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02017Tetrahydrofolate synthase (6.3.2.17)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses construction of pichia pastoris genetic engineering bacteria and application thereof in improving methanol assimilation rate and fixing carbon dioxide, wherein a methanol metabolism path of pichia pastoris is modified, and a reducing glycine path is reconstructed by knocking out a dissimilation path, so that carbon atom loss caused by carbon dioxide generated by dissimilation is eliminated, and the utilization efficiency of carbon atoms is improved. In order to further improve the assimilation of methanol and carbon dioxide, the preferred compartmentalization rational design is carried out on the methanol catabolism path of the pichia pastoris, the biomass of the metabolizing modified strain can be improved by 8.7 percent, compared with the original pichia pastoris GS115, the genetically engineered strain has the same methanol consumption rate, but obvious formic acid accumulation of about 0.66g/L, and further proves that the pichia pastoris genetically engineered strain uses more carbon for central metabolism.

Description

Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide
Technical Field
The invention belongs to the field of strain metabolism transformation, and particularly relates to construction of a Pichia pastoris genetically engineered bacterium and application of the Pichia pastoris genetically engineered bacterium in improving methanol assimilation rate and fixing carbon dioxide.
Background
Global food shortage has prompted the search for alternative sources of raw materials for biofuel or chemical production. Methanol is a non-food-derived C1 feedstock and is becoming an attractive alternative to industrial bio-production due to its low price and high energy content. Methanol can be readily produced from coal, natural gas or other renewable resources with annual production capacity exceeding 1 million tons worldwide. In recent years, by CO 2 The technology of synthesizing methanol by hydrogenation is broken through. The development of methanol bio-production is a key factor in establishing sustainable cycle carbon economy.
Methylotrophic bacteria are microorganisms that are capable of growing on methanol and providing a carbon source and an energy source with methanol, both of which are necessary for methanol bio-production. Many natural methylotrophic bacteria, such as methanobacteria and methanobacteria, have recently been identified and used to produce single cell proteins, PHB or amino acids. In addition, some model organisms, such as E.coli, saccharomyces cerevisiae and Corynebacterium glutamicum, are also designed for methanol assimilation. Wherein Pichia pastoris is preparedP.pastoris)Is reclassified asKomagatella phaffiiIs representative of methylotrophic yeasts. Pichia pastoris grows faster on methanol medium than the bacterial methylotrophic bacteria. The high cell density fermentation of Pasteurella in minimal media is easy to achieve and various fermentation strategies have been established with strict control by methanol.
All these characteristics mean that pichia pastoris has a greater potential for large-scale industrial use than other representative methylotrophic organisms. Some biopharmaceuticals or proteins produced by pichia pastoris have been marketed. However, the methanol utilization rate of Pichia pastoris is low, and most of carbon flow generates CO through a dissimilation path 2 Loss, furthermore, the energy in the methanol assimilation pathway is limited to the XuMP cycle and cannot be fully used for product production. Pichia pastoris is a chassis cell with lower methanol utilization efficiency.
Disclosure of Invention
Aiming at the problem of low methanol utilization efficiency of pichia pastoris, the invention provides the construction of the pichia pastoris genetic engineering bacterium and the application of the pichia pastoris genetic engineering bacterium in improving the methanol assimilation rate and fixing carbon dioxide, which not only can solve the problem of carbon atom waste, but also can endow pichia pastoris with carbon fixation and carbon atom reutilization capability to further improve the utilization efficiency of carbon atoms.
The construction of the Pichia pastoris genetic engineering bacteria comprises the following steps:
step 1, respectively designing primers corresponding to a reductive glycine pathway related gene MIS1, a reductive glycine pathway related gene GCV2 and a reductive glycine pathway related gene GCV3, using pichia pastoris GS115 genome as a template, and obtaining MIS1, GCV2 and GCV3 gene fragments corresponding to the primers respectively by PCR amplification, wherein the nucleic acid sequence of an upstream primer MIS1-F used by MIS1 is shown as SEQ ID No. 1, and the nucleic acid sequence of a downstream primer MIS1-R is shown as SEQ ID No. 2; the nucleic acid sequence of the upstream primer GCV1-F used by the GCV1 is shown as SEQ ID No. 3, the nucleic acid sequence of the downstream primer GCV1-R is shown as SEQ ID No. 4, the nucleic acid sequence of the upstream primer GVC2-F used by the GCV2 is shown as SEQ ID No. 5, the nucleic acid sequence of the downstream primer GVC 2-R is shown as SEQ ID No. 6, the nucleic acid sequence of the upstream primer used by the GCV3 is shown as SEQ ID No. 7, and the nucleic acid sequence of the downstream primer GCV3-R is shown as SEQ ID No. 8;
step 2, knocking out FDH genes in a dissimilation pathway in Pichia pastoris GS115 by using a CRISPR-Cas9 gene knockout technology to obtain a recombinant strain GS 115-delta FDH;
step 3, constructing recombinant plasmids pGAP-MIS1-P2A-GCV1 and pGAP-GCV2-P2A-GCV3, and a knockout plasmid pET28a-His for knocking out DAS genes, wherein the recombinant plasmid pGAP-MIS1-P2A-GCV1 is a recombinant plasmid containing the MIS1 gene fragment and the GCV1 gene fragment amplified in the step 1, the recombinant plasmid pGAP-GCV2-P2A-GCV3 is a recombinant plasmid containing the GCV2 gene fragment and the GCV3 gene fragment amplified in the step 1, the amino acid sequence coded by the MIS1 gene fragment is shown as SEQ ID No. 9, and the amino acid sequence coded by the GCV1 gene fragment is shown as SEQ ID No. 10; the amino acid sequence of the GCV2 gene fragment is shown as SEQ ID No. 11, and the amino acid sequence of the GCV3 gene fragment is shown as SEQ ID No. 12.
Step 4, recombinant plasmids pGAP-MIS1-P2A-GCV1 and pGAP-GCV2-P2A-GCV3 are introduced into pichia pastoris GS 115-delta FDH, and double-crossover homologous recombination is carried out by using knockout plasmid pET28a-His to knockout DAS genes in pichia pastoris, so that the original methanol assimilation way is replaced by a reductive glycine way;
step 5, constructing a recombinant plasmid pIC9K-FLD-P2A-FGH-PTS1, wherein the recombinant plasmid pIC9K-FLD-P2A-FGH-PTS1 comprises FLD gene fragments, FGH gene fragments and PTS1 signal peptide, carrying out PCR amplification on Pichia pastoris GS115 methanol catabolism pathway FLD and FGH genes by using specific primers, and adding PTS1 signal peptide at the sequence C end to position the catabolism pathway in a peroxisome, wherein the amino acid sequence coded by the FGH gene fragments is shown as SEQ ID No. 13, and the amino acid sequence coded by the FLD gene fragments is shown as SEQ ID No. 14;
and 6, introducing the recombinant plasmid pIC9K-FLD-P2A-FGH-PTS1 into the recombinant pichia pastoris constructed in the step 4, and realizing compartmentalization positioning expression of a pichia pastoris methanol catabolism pathway to obtain the pichia pastoris genetic engineering bacteria.
As an improvement, the reaction conditions of the PCR described in step 1 are: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min.
SEQ ID No .1:
TATTTCGAAACGAGGAATTGAAACGATGCTTTCAAGAATTGGATCTAGAAATAAAG;
SEQ ID No .2:
ACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCAAATAA;
SEQ ID No .3:
TAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTGAAACGA;
SEQ ID No .4:
AGATGAGTTTTTGTTCTAGTCACTCCGGCTTATAAAATTTGGGGGC;
SEQ ID No .5:
TATTTCGAAACGAGGAATTGAAACGATGTTAAGAACCCAGTTCTCCA;
SEQ ID No .6:
TCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTTGACTAGCA;
SEQ ID No .7:
TGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTGAAACGA;
SEQ ID No .8:
ATGATGATGATGATGGTCGATTAGCTTTCCTCCTGCAAAAACTTGAC。
SEQ ID No .9
MLSRIGSRSKATSTVRRLAGDLLLGSRKLHASAVFSQAQILSGTKLAKSIRSKVFEEINVFKATHPEFQPAVTIIQVGDRPDSSAYVRMKLKAASESGIICNVIKLPEDTAEPTLINRIHKLNNDNSVHGILVQLPLPSHIDETHITNSVSILKDVDGFDRFNVGELAKKGGNPTFLPCTPNGCMKLLEASGVELSGKSAVVLGRSDIVGTPVAQLLNKANCTVTVCHSRTPNIAEIVKNSDIVVAAIGKANFVKGEWLKPGAVVIDVGINYVPDPTKKSGQRLVGDVEFESAKEKASVITPVPGGVGPMTVAMLVSNIAHAAKLQLENDLKPAKIYANPLELKTPVPSDIEISRAQEPRYIKDIATDLGIKDKELELYGHYKAKVSLDVYDRLAKNRENGNYVLVAGITPTPLGEGKSTTTMGLVQALGAHLNLAAVANVRQPSMGPTFGVKGGAAGGGYAQVIPMDEFNMHLTGDIHAIGAANNLLAAALDTRIFHETTQRDAIFYKRLVPAKKGVRKFTPSMLKRLEKLGINKTEPDSLTPEEATKFAKLNIDPQTITVKRVLDVNDRFVRQVTIGEAPTEKGHIRKTGFDITVASEVMAILALSKDLKDLRSRVGAIVVASSYEGVPITAEDLGVAGALTALLKDAVKPNLMQTLEGTPVFVHAGPFANISIGASSVIADRVALKLIGASKSDVVAKSEKGFVVTEAGFDFTMGGERFYNIKCRASGLKPNTVVLVATSRALKLHGGAPDVKPGQALPEEYTTENVELVRRGCANLAKQISNASQYGAPVVVAINQFETDSPAELSVIREEALKAGAFDAVPSNHWAEGGKGAVELAKAVVSSCASCPEPNAEKAELYSLENNTIEDRLNTIVQKMYNGDGIELSELAKEQIARYEAQGFGNLPICIAKTQYSLSHDPSLKNVPAGFTVPIREVRLSAGAGYLSCLAAEIMTIPGLPTHPGYLNVEVNDDGEIEGLF
SEQ ID No .10
MIRSCRRYSTGVEALIKTPLYSVHVEHGATLVPYANFAMPVLYKGQSHIESHNWTRSKVGIFDVSHMLQHRVKGNSAAEFLQKITPSDLKALKPFTSTLSVLLNDKGGVIDDCIITKHDENEFYIVTNAGCRDKDTSFIKEEISQFGNASHENFEGTLLAIQGPQAAETLQKFTNLDLTKLYFGNSAFAKLEGFTSDVIHIARSGYTGEDGFELSIPVDSEGLEFTKALLELEQVKPIGLAARDSLRLEAGMCLYGHELNEQTTPVESSLNWLIAKSRRTPKTAGFNGSENILSQLENPKSVTFKRVGIQSKGPSPREGNKVYSFEEPDKQIGVVCSGSPSPTLGGNVGQAFIHKPHQKAGTKILIEIRNKKREAHVAKLPFVAPKFYKPE
SEQ ID No .11
MLRTQLSKALLKSHSVKAWARVGTATTSRFVSDTTSATFRSIYEKGSSTPSPYDGTDSFPRRHLGPTPNNVDEMLQDLKESDLDSFIAKVVPDNVLIRRSLKVEPLKGFTESEMLAELARIAEKNDLVKPLIGKGFYGTIIPPVILRNLLENPGWYTSYTPYQPEVSQGRLESLLNFQTVISDLTGLPVANASLLDESSAAAEAMILSFTSLKSKKPKYFVDSNIHEQTLAVLKSRAHTLSIEVVVADLTTDEGFAALQENKDQLCGAMVQYPATDGSIETFKAYSRIAELVHSVKGLYAVASDLMALTLLHAPSKFGADIVFGSSQRFGVPLGYGGPHAAFFSVVESLQRKIPGRIVGVSKDRLGNNALRLALQTREQHIKRERATSNICTAQALLANIAANYVVYHGIEGLRNISKRIHGFTTLLANSINESSSHKVLNEKWFDTLSVDVGSADEFIAKALSKNFNVFRVNNSTIQLSLDETVTKNELTTLISLFTGSSEVNLPETLPSFYEEWTRQDDILTNEVFRTHRSETSMLRYLTHLQKKDISLADSMISLGSCTMKLNATVEMMPISWPKFANIHPFAPKDQVKGYTELIVELEKDLADITGFHSTTLQPNSGAQGEYTGLSVIAKYFESKGEAHRNIVLIPVSAHGTNPASAAMAGLKVVPIKCLKDGSLDLQDLESKASKHAKNLAAMMVTYPSTYGLFEPGIIDAIKIIHNHGGQVYLDGANMNAQVGLTSPGDLGADVCHLNLHKTFAIPHGGGGPGVGPICVKEHLTPFLPSHPIIATTNQTEQSINPVVAAPFGSASILPISYAYIKMMGGSNLQYSSIIAILNANYMVAKLKNHFEILFTGGDAKYCGHEFIIDLRPFKKFGIEAIDVAKRLQDYGFHAPTMSFPIPGTLMVEPTESEYKEELDRFIDSMISIREEIRKVENGETDGAILHNSPHNLKDIISTSDAEWSQRGYTREEAAYPLPFLKEQKTWPTVSRVDDTYGDMNLLCTCPSVEEVAASQ
SEQ ID No .12
MLRTQLSKALLKSHSVKAWARVGTATTSRFVSDTTSATFRSIYEKGSSTPSPYDGTDSFPRRHLGPTPNNVDEMLQDLKESDLDSFIAKVVPDNVLIRRSLKVEPLKGFTESEMLAELARIAEKNDLVKPLIGKGFYGTIIPPVILRNLLENPGWYTSYTPYQPEVSQGRLESLLNFQTVISDLTGLPVANASLLDESSAAAEAMILSFTSLKSKKPKYFVDSNIHEQTLAVLKSRAHTLSIEVVVADLTTDEGFAALQENKDQLCGAMVQYPATDGSIETFKAYSRIAELVHSVKGLYAVASDLMALTLLHAPSKFGADIVFGSSQRFGVPLGYGGPHAAFFSVVESLQRKIPGRIVGVSKDRLGNNALRLALQTREQHIKRERATSNICTAQALLANIAANYVVYHGIEGLRNISKRIHGFTTLLANSINESSSHKVLNEKWFDTLSVDVGSADEFIAKALSKNFNVFRVNNSTIQLSLDETVTKNELTTLISLFTGSSEVNLPETLPSFYEEWTRQDDILTNEVFRTHRSETSMLRYLTHLQKKDISLADSMISLGSCTMKLNATVEMMPISWPKFANIHPFAPKDQVKGYTELIVELEKDLADITGFHSTTLQPNSGAQGEYTGLSVIAKYFESKGEAHRNIVLIPVSAHGTNPASAAMAGLKVVPIKCLKDGSLDLQDLESKASKHAKNLAAMMVTYPSTYGLFEPGIIDAIKIIHNHGGQVYLDGANMNAQVGLTSPGDLGADVCHLNLHKTFAIPHGGGGPGVGPICVKEHLTPFLPSHPIIATTNQTEQSINPVVAAPFGSASILPISYAYIKMMGGSNLQYSSIIAILNANYMVAKLKNHFEILFTGGDAKYCGHEFIIDLRPFKKFGIEAIDVAKRLQDYGFHAPTMSFPIPGTLMVEPTESEYKEELDRFIDSMISIREEIRKVENGETDGAILHNSPHNLKDIISTSDAEWSQRGYTREEAAYPLPFLKEQKTWPTVSRVDDTYGDMNLLCTCPSVEEVAASQ
SEQ ID No .13
MSSITTSIFKVTAEIQSFGGKLVKLQHKSDETKTDMDVNVYLPAQFFANGAKGKSLPVLLYLSGLTCTPNNASEKAFWQPYANKYGFAVVFPDTSPRGLNIEGEHDSYDFGSGAGFYVDATTEKWKDNYRMYSYVNSELLPKLQADFPILNFDNISITGHSMGGYGALQLFLRNPGKFKSVSAFSPISNPTKAPWGEKCFSGYLGQDKSTWTQYDPTELIGKYQGPSDSSILIHVGKSDSFYFKDHQLLPENFLKASENSVFKGKVDLNLVDGYDHSYYFISSFTDVHAAHHAKYLGLN
SEQ ID No .14
MSTEGQIIKCKAAVAWEAGKDLSIEEIEVLPPRAHEVRVKVEFTGVCHTDAYTLSGADAEGSFPVVFGHEGAGVVESVGEGVESVKVGDSVVLLYTPECRECKFCLSGKTNLCGKIRATQGKGLLPDGTSRFRCKGKDLFHYMGCSSFSQYTVVADISVVKVQDEAPKDKTCLLGCGVTTGYGAAINTAKISKGDKIGVFGAGCIGLSVIQGAVSKGASEIIVIDINDSKKAWADQFGATKFVNPTTLPEGTNIVDYLIDITDGGFDYTFDCTGNVQVMRNALESCHKGWGESIIIGVAAAGKEISTRPFQLVTGRVWRGCAFGGIKGRTQMPSLVQDYLDGKIKVDEFITHRHDLDNINKAFHDMHAGNCIRAVITMH
SEQ ID No .15:
CAACTAATTATTCGAAGGATCCGAAACGATGTCATCAATTACTACTTCAATCTTCAAG
SEQ ID No .16:
CACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCCAACTTAGAGTTTAACCCCAAATACTTTGCATGGTG
SEQ ID No .17:
TGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTGAAACGATGTCTACCGAAGGTCAAGTAAGTTCAAT
SEQ ID No .18:
AAGGCGAATTAATTCGCGGCCGCTTACAACTTAGAGTGCATAGTAATCACAGCAC
The application of the pichia pastoris genetically engineered bacteria in improving the methanol efficiency and fixing the carbon dioxide comprises the following specific steps: firstly, selecting positive clone of pichia pastoris genetic engineering bacteria, transferring to an M9 culture medium after shaking overnight culture, and culturing by taking methanol as a unique carbon source; second, sampling every 24 hours and drawing a growth curve in the process of culturing cells, and using OD 600 The measurement is carried out, and the biomass is finally measured.
The beneficial effects are that:
compared with the prior art, the construction of the pichia pastoris genetic engineering bacteria and the application thereof in improving the methanol assimilation rate and fixing the carbon dioxide are realized, the methanol metabolism pathway of pichia pastoris is modified, the carbon atom loss caused by carbon dioxide generated by dissimilation is eliminated by knocking out the dissimilation pathway and reconstructing the reductive glycine pathway, the carbon atom utilization efficiency is improved, the utilization efficiency of methanol by the bacteria strain subjected to metabolic modification and compartmentalization design is improved, and the carbon dioxide can be fixed by utilizing the reductive glycine pathway for improving the biomass.
The method has the specific advantages that:
1. the overexpressed gene related to the glycine pathway is cloned from pichia pastoris for the first time, and has low cost, simple molecular level operation, easy cloning and expression and better repeatability;
2. the modified strain constructed in the invention knocks out the dissimilation path thereof, thereby avoiding carbon flow from using CO 2 The form loss of the pichia pastoris improves the utilization efficiency of the carbon atoms of the methanol;
3. the modified strain constructed in the invention has the capability of fixing carbon dioxide on the overexpressed reductive glycine path, thereby enabling pichia pastoris to be modified into autotrophic strain;
4. the biomass of the compartmentalized recombinant strain constructed in the invention is improved by 8.7%, and the methanol assimilation efficiency is further improved.
Drawings
FIG. 1 is a diagram of a related plasmid of the present invention wherein (a) pGAP-MIS1-P2A-GCV1; (b) pGAP-GCV2-P2A-GCV3, (c) pET28a-His; (d) pIC9K-FLD-P2A-FGH-PTS1
FIG. 2 is a recombinant strain fermentation characterization wherein (a) the DAS gene knockout strain is fermentation verified; (b) Green fluorescent positioning of FGH-TPS1, (c) red fluorescent positioning of FDH-TPS1, (d) fermentation verification of recombinant strain; (e) Methanol consumption of fermentation Strain (f) accumulation of fermentation fungus formic acid
FIG. 3 shows the result of related gene amplification;
FIG. 4 is a diagram of recombinant strains 13 C carbon dioxide labeling.
Detailed Description
The invention is further illustrated by the following description of specific embodiments, which are not intended to be limiting, and various modifications or improvements can be made by those skilled in the art in light of the basic idea of the invention, but are within the scope of the invention without departing from the basic idea of the invention.
The techniques not mentioned in the examples are conventional in the art, and in addition, materials such as the Pichia pastoris GS115 source ATCC, trans1-T1, pXY3, top10 and the like are all commercial products and can be purchased directly.
Example 1
And knocking out the FDH gene in the catabolism pathway in pichia pastoris by using a CRISPR-Cas9 gene knockout technology to obtain a recombinant strain GS 115-delta FDH.
Example 2
1. Construction of pGAPZA-MIS1-P2A-GCV1 recombinant plasmid
The nucleotide coding sequence of the corresponding gene was replicated by conventional PCR amplification using Pichia pastoris GS115 genome with MIS1, GVC1 genes as a template.
The MIS1 upstream primer used has a homology arm and has the sequence:
MIS1-F:TATTTCGAAACGAGGAATTGAAACGATGCTTTCAAGAATTGGATCTAGAAATAAAG
the MIS1 downstream primer has a P2A sequence as a homology arm, and the sequence is:
MIS1-R:
ACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCAAATAA。
the GCV1 upstream primer used has a P2A sequence as a homology arm, and the sequence is:
GCV1-F:TAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTGAAACGA
the GCV1 downstream primer has a homology arm and has the sequence:
GCV1-R:
AGATGAGTTTTTGTTCTAGTCACTCCGGCTTATAAAATTTGGGGGC。
the reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; the obtained sequence was subjected to 1% agarose gel electrophoresis at 72℃for 5 min, and the corresponding fragment was recovered.
The recovered fragments were added as templates to the upper primer MIS1-F and the lower primer GCV1-R was used to join the two fragments together using OVERLAP PCR. The reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; the obtained sequence was subjected to 1% agarose gel electrophoresis at 72℃for 5 min, and the corresponding fragment was recovered.
The expression vector pGAP was digested with Sal I and EcoR I of Takara, the digestion reaction system was: 10 Xbuffer 1. Mu.L, sal I1. Mu.L, ecoR I1. Mu.L, pGAP vector 7. Mu.L. The cleavage system was reacted at 37℃for 2 hours. The 15-20 bp sequence at the end of the linearized vector after cleavage was used as homology arm and added to the 5' end of the gene-specific upstream and downstream primer sequences (MIS 1-F, GCV 1-R), respectively. The recombination reaction system is as follows: 5X CE II buffer 4. Mu.L of Vazyme, 2. Mu.L of Exnase II, 10. Mu.L of gene fragment and 2. Mu.L of vector were used. The ligation was carried out at 37℃for 1 hour. The ligation product was transformed into E.coli Trans1-T1. The positive strain Trans 1-T1-pGAP-MIS 1-P2A-GCV1 was screened by PCR and DNA sequencing was performed to verify that the recombinant plasmid was constructed correctly (FIG. 1 (a)).
The positive strain was inoculated into 5 mL of LB/KanR liquid medium consisting of peptone 10 g/L, yeast powder 5 g/L, sodium chloride 5 g/L, and cultured overnight at 37℃under shaking at 200 rpm. The plasmid pGAP-MIS1-P2A-GCV1 was extracted 24 hours later according to the instructions of the Tiangen plasmid extraction kit. mu.L of pGAP-MIS1-P2A-GCV1 plasmid was electrotransformed into Pichia pastoris which had knocked out the catabolism pathway. The positive strain GS115-MIS1-P2A-GCV1 was screened by PCR.
2. Construction of pGAP-GCV2-P2A-GCV3 recombinant plasmid
The nucleotide coding sequence of the GCV2 and GCV3 genes is amplified and copied by conventional PCR by taking pichia pastoris genome as a template.
The GCV2 upstream primer used has a homology arm and has the sequence:
GCV2-F:TATTTCGAAACGAGGAATTGAAACGATGTTAAGAACCCAGTTCTCCA
the GCV2 downstream primer has a P2A sequence as a homology arm, and the sequence is:
GCV2-R:
TCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTTGACTAGCA。
the GCV3 upstream primer used had the P2A sequence as homology arm and the sequence was:
GCV3-F:
TGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTGAAACGA
the GCV3 downstream primer has a homology arm and has the sequence:
GCV3-R:
ATGATGATGATGATGGTCGATTAGCTTTCCTCCTGCAAAAACTTGAC。
the reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min. The resulting sequence was subjected to 1% agarose gel electrophoresis and the corresponding fragment was recovered.
The recovered fragments were added as templates to the upper primer GCV2-F and the lower primer GCV3-R was used to join the two fragments together using OVERLAP PCR. The reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; the obtained sequence was subjected to 1% agarose gel electrophoresis at 72℃for 5 min, and the corresponding fragment was recovered.
The expression vector pGAP was digested with Sal I and EcoR I of Takara, the digestion reaction system was: 10 Xbuffer 1. Mu.L, sal I1. Mu.L, ecoR I1. Mu.L, pGAP vector 7. Mu.L. The cleavage system was reacted at 37℃for 2 hours. The 15-20 bp sequence at the end of the linearized vector after cleavage was used as homology arm and added to the 5' end of the gene specific upstream and downstream primer sequences (GVC 2-F, GVC 3-R), respectively. The recombination reaction system is as follows: 5X CE II buffer 4. Mu.L of Vazyme, 2. Mu.L of Exnase II, 10. Mu.L of gene fragment and 2. Mu.L of vector were used. The ligation was carried out at 37℃for 1 hour. The ligation product was transformed into E.coli Trans1-T1. The colony PCR was used to screen the positive strain Trans 1-T1-pGAP-GCV 2-P2A-GCV3 and to verify that the recombinant plasmid was constructed correctly (FIG. 1 (b)).
The positive strain was inoculated into 5 mL of LB/KanR liquid medium consisting of peptone 10 g/L, yeast powder 5 g/L, sodium chloride 5 g/L, and cultured overnight at 37℃under shaking at 200 rpm. Extracting plasmid pGAP-GCV2-P2A-GCV3 according to the operation instruction of a root plasmid extraction kit after 24 hours, taking 2 mu L of pGAP-GCV2-P2A-GCV plasmid, electrically transforming into pGAP-GCV2-P2A-GCV3 pichia pastoris, and carrying out PCR screening on positive strain GS115-MIS1-P2A-GCV1-GCV21-P2A-GCV3, wherein the obtained recombinant strain is named as follows: GS115- ΔFDH-rGly
3. Construction of pET28a-His recombinant plasmid
The nucleotide coding sequence of the homology arm was amplified by conventional PCR using Pichia pastoris genome with the upper and lower homology arms of the DAS gene as a template.
The upper homology arm upstream primer is provided with a homology arm, and the sequence is as follows:
S-F:
GTGGTGGTGGTGGTGCTCGAGGGTACTCTTTGACATAGCTATCAACTAACTTTTTCC
the downstream primer of the upper homology arm is provided with a homology arm, and the sequence is as follows:
S-R:
GAAACTGGGACTTATTTAAATGGCTAGAATTCCAAAAGCAGTATCG。
the upper stream of the lower homology arm is provided with a homology arm, and the sequence is as follows:
X-F:
ACGGAGCTCGAATTCGGATCCATGGCTAGAATTCCCAAAGCAGTTT
the downstream primer of the lower homology arm is provided with a homology arm, and the sequence is as follows:
X-R:
GGTGCCGCGCGGCAGCCATATGGATAGTTCTTAACGTACTCATCCAAAAGTTTCTTCC。
the reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min. The resulting sequence was subjected to 1% agarose gel electrophoresis and the corresponding fragment was recovered.
The nucleotide coding sequence of the histidine-screening tag was amplified by conventional PCR using the pPIC9k plasmid with the histidine-screening tag gene as a template.
The upstream primer of the histidine screening tag gene is provided with a homology arm, and the sequence is as follows:
H-F: TTTTGGAATTCTAGCCATTTAAATAAGTCCCAGTTTCTCCATACGAACC
the downstream primer of the histidine screening tag gene is provided with a homologous arm, and the sequence is as follows:
H-R:
CCGAATTCGAGCTCCGTCGACTCAGAATTGGTTAATTGGTTGTAACACTGGC。
the reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min. The resulting sequence was subjected to 1% agarose gel electrophoresis and the corresponding fragment was recovered.
The recovered fragments were used as templates for addition to the upper primer S-F and the lower primer X-R, which were used to join the three fragments together using OVERLAP PCR. The reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min. The resulting sequence was subjected to 1% agarose gel electrophoresis and the corresponding fragment was recovered.
The expression vector pET28a was digested with Nde I and Xho I from Takara, and the digestion reaction system was: 10 Xbuffer 1. Mu.L, nde I. Mu.L, xho I1. Mu.L, pET28a vector 7. Mu.L. The cleavage system was reacted at 37℃for 2 hours. The 15-20 bp sequence at the end of the linearized vector after cleavage was used as homology arm and added to the 5' end of the gene-specific upstream and downstream primer sequences (S-F, H-R), respectively. The recombination reaction system is as follows: 5X CE II buffer 4. Mu.L of Vazyme, 2. Mu.L of Exnase II, 10. Mu.L of gene fragment and 2. Mu.L of vector were used. The ligation was carried out at 37℃for 1 hour. The ligation product was transformed into E.coli Trans1-T1. The positive strain Trans 1-T1-pET 28a-His was screened by PCR and DNA sequencing was performed to verify that the recombinant plasmid was constructed correctly (FIG. 1 (c)).
The positive strain was inoculated into 5 mL of LB/KanR liquid medium consisting of peptone 10 g/L, yeast powder 5 g/L, sodium chloride 5 g/L, and cultured overnight at 37℃under shaking at 200 rpm. After 24 hours, 2. Mu.L of pET28a-His plasmid was electrotransformed into GS 115-. DELTA.FDH-rGly Pichia pastoris according to the instructions of the day root plasmid extraction kit. The positive strain GS 115-DeltaFDH-rGly-DeltaDAS was screened by PCR.
Similarly, 2. Mu.L of pET28a-His plasmid was electrotransformed into Pichia pastoris GS 115. Positive strain GS115- Δdas was screened by PCR.
4. Construction of pIC9K-FLD-P2A-FGH-PTS1 recombinant plasmid
The Pichia genome with FGH and FLD genes is used as template to amplify and copy the nucleotide coding sequence of the gene by conventional PCR.
The FGH upstream primer used had a homology arm with the sequence:
FGH-F:
TATTTCGAAACGAGGAATTGAAACGATGTTAAGAACCCAGTTCTCCA
FGH downstream primer has P2A sequence as homology arm, and the sequence is:
FGH-R:
CACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCCAACTTAGAGTTTAACCCCAAATACTTTGCATGGTG。
the FLD upstream primer used has a P2A sequence as a homology arm, and the sequence is:
FLD-F:
TGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTGAAACGATGTCTACCGAAGGTCAAGTAAGTTCAAT。
the FLD downstream primer has a homology arm and has the sequence:
FLD-R:
AAGGCGAATTAATTCGCGGCCGCTTACAACTTAGAGTGCATAGTAATCACAGCAC。
the reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min. The resulting sequence was subjected to 1% agarose gel electrophoresis and the corresponding fragment was recovered.
The recovered fragment was used as template to add to the upper primer FGH-F and the lower primer FLD-R to join the two fragments together using OVERLAP PCR. The reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; the obtained sequence was subjected to 1% agarose gel electrophoresis at 72℃for 5 min, and the corresponding fragment was recovered.
The expression vector PIC9K was digested with BamH I and Not I from Takara, and the digestion reaction system was: 10 Xbuffer 1. Mu.L, bamH 1. Mu.L, not I1. Mu.L, PIC9K vector 7. Mu.L. The enzyme digestion system is reacted for 1 hour at 30 ℃ before the reaction for 1 hour at 37 ℃. The 15-20 bp sequence at the end of the linearized vector after cleavage was used as homology arm and added to the 5' end of the gene-specific upstream and downstream primer sequence (FGH-F, FLD-R), respectively. The recombination reaction system is as follows: 5X CE II buffer 4. Mu.L of Vazyme, 2. Mu.L of Exnase II, 10. Mu.L of gene fragment and 2. Mu.L of vector were used. The ligation was carried out at 37℃for 1 hour. The ligation product was transformed into E.coli Trans1-T1. The colony PCR was used to screen the positive strain Trans 1-T1-pIC 9K-FLD-P2A-FGH-PTS1 and to verify that the recombinant plasmid was constructed correctly (FIG. 1 d).
The positive strain was inoculated into 5 mL of LB/KanR liquid medium consisting of peptone 10 g/L, yeast powder 5 g/L, sodium chloride 5 g/L, and cultured overnight at 37℃under shaking at 200 rpm. The plasmid pIC9K-FLD-P2A-FGH-PTS1 was extracted 24 hours later according to the instructions of the day root plasmid extraction kit. mu.L of pIC9K-FLD-P2A-FGH-PTS1 plasmid was electrotransformed into GS115- ΔFDH-rGly- ΔDAS Pichia pastoris, and positive strains were screened by colony PCR, and the obtained recombinant strains were named as follows: GS115- ΔFDH-rGly- ΔDAS-FGH-FLD-TPS1.
5. Construction of compartmentalized characterization Strain GS115-FGH-PTSI-GFP, GS115-FLD-PTS1-RFP
The Pichia genome with FGH and FLD genes is used as template to amplify and copy the nucleotide coding sequence of the gene by conventional PCR.
The FGH upstream primer used had a homology arm with the sequence:
FGH-F:
AACTAATTATTCGAAGGATCCATGTCATCAATTACTACTTCAATCTTCAAGGTAACAG
FGH downstream primer has linker sequence as homology arm, and the sequence is:
FGH-R:
CACCGCCAGAGCCACCTCCGCCGTTTAACCCCAAATACTTTGCATGGTGAG。
the GFP upstream primer used carries a linker sequence as a homology arm, and the sequence is:
GFP-F:
GGTGGCTCTGGCGGTGGCGGATCGATGGTGAGCAAGGGCGAG。
the GFP downstream primer has a PTS1 sequence homology arm, and the sequence is:
GFP-R:
AAGGCGAATTAATTCGCGGCCGCTTACAACTTAGACTTGTACAGCTCGTCCAT。
the reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min. The resulting sequence was subjected to 1% agarose gel electrophoresis and the corresponding fragment was recovered.
The recovered fragments were added as templates to the upper primer FGH-F and the lower primer GFP-R was used to join the two fragments together using OVERLAP PCR. The reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; the obtained sequence was subjected to 1% agarose gel electrophoresis at 72℃for 5 min, and the corresponding fragment was recovered.
The expression vector PIC9K was digested with BamH I and Not I from Takara, and the digestion reaction system was: 10 Xbuffer 1. Mu.L, bamH 1. Mu.L, not I1. Mu.L, PIC9K vector 7. Mu.L. The enzyme digestion system is reacted for 1 hour at 30 ℃ before the reaction for 1 hour at 37 ℃. The 15-20 bp sequence at the end of the linearized vector after cleavage was used as homology arm and added to the 5' end of the gene-specific upstream and downstream primer sequences (FGH 2-F, GFP-R), respectively. The recombination reaction system is as follows: 5X CE II buffer 4. Mu.L of Vazyme, 2. Mu.L of Exnase II, 10. Mu.L of gene fragment and 2. Mu.L of vector were used. The ligation was carried out at 37℃for 1 hour. The ligation product was transformed into E.coli Trans1-T1. The colony PCR is used for screening a positive strain Trans 1-T1-pIC 9K-FGH-GFP-PTS 1, and the construction of a recombinant plasmid is verified to be correct.
The positive strain was inoculated into 5 mL of LB/KanR liquid medium consisting of peptone 10 g/L, yeast powder 5 g/L, sodium chloride 5 g/L, and cultured overnight at 37℃under shaking at 200 rpm. The plasmid pIC 9K-FGH-GFP-PTS 1 was extracted 24 hours later according to the instructions of the day root plasmid extraction kit. mu.L of pIC 9K-FGH-GFP-PTS 1 plasmid was electrotransformed into GS115 in Pichia pastoris, and positive strains were screened by colony PCR, and the obtained recombinant strains were named as follows: GS 115-FGH-GFP-PTS 1.
The FLD upstream primer has a homology arm and has the sequence:
FLD-F:
TTATTCGAAGGATCCGAAACGATGTCTACCGAAGGTCAAGTAAGTTCAAT。
the FLD2 downstream primer has a linker sequence as a homology arm, and the sequence is:
FLD2-R:
CACCGCCAGAGCCACCTCCGCCGTGCATAGTAATCACAGCACGAATACAG。
the RFP upstream primer is provided with a linker sequence as a homology arm, and the sequence is as follows:
RFP-F:
GGTGGCTCTGGCGGTGGCGGATCGATGGTGCGCTCCTCCAAG。
the RFP downstream primer has a PTS1 sequence homology arm, and the sequence is as follows:
RFP-R:
AGTTTTTGTTCTAGGCGGCCGCTTACAACTTAGACAGGAACAGGTGGTG。
the reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min. The resulting sequence was subjected to 1% agarose gel electrophoresis and the corresponding fragment was recovered.
The recovered fragment was used as a template to add to the upper primer FLD-F, and the lower primer RFP-R was used to join the two fragments together using OVERLAP PCR. The reaction conditions are as follows: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; the obtained sequence was subjected to 1% agarose gel electrophoresis at 72℃for 5 min, and the corresponding fragment was recovered.
The expression vector PGAPZA was digested with BamH I and Not I from Takara, and the digestion reaction system was: 10 Xbuffer 1. Mu.L, bamH 1. Mu.L, not I1. Mu.L, PIC9K vector 7. Mu.L. The enzyme digestion system is reacted for 1 hour at 30 ℃ before the reaction for 1 hour at 37 ℃. The 15-20 bp sequence at the end of the linearized vector after cleavage was used as homology arm and added to the 5' end of the gene specific upstream and downstream primer sequence (FLD-F, RFP-R), respectively. The recombination reaction system is as follows: 5X CE II buffer 4. Mu.L of Vazyme, 2. Mu.L of Exnase II, 10. Mu.L of gene fragment and 2. Mu.L of vector were used. The ligation was carried out at 37℃for 1 hour. The ligation product was transformed into E.coli Trans1-T1. The colony PCR is used for screening a positive strain Trans 1-T1-pGAPZA-FLD-RFP-PTS 1, and the construction of a recombinant plasmid is verified to be correct.
The positive strain was inoculated into 5 mL of LB/KanR liquid medium consisting of peptone 10 g/L, yeast powder 5 g/L, sodium chloride 5 g/L, and cultured overnight at 37℃under shaking at 200 rpm. The plasmid pGAPZA-FLD-RFP-PTS 1 was extracted 24 hours later according to the procedure of the day root plasmid extraction kit. mu.L of pGAPZA-FLD-RFP-PTS 1 plasmid was electrotransformed into GS115 in Pichia pastoris, and positive strains were selected by colony PCR, and the obtained recombinant strains were named as follows: GS 115-FLD-RFP-PTS 1.
EXAMPLE 3 phenotypic verification of recombinant strains
1. Knock-out strain fermentation verification
After the DAS gene knockout is verified, the pichia pastoris assimilation effect is verified, and pichia pastoris GS115 and GS 115-delta DAS strains are respectively inoculated into 5 mL YPD liquid culture medium and are subjected to shake culture at 30 ℃ and 200 rpm until OD600 is approximately equal to 5. The cultured bacterial solutions are all according to the initial OD 600 After centrifugation and resuspension of =0.2, the samples were inoculated into 100mL of fresh M9 liquid medium and 1% methanol was added thereto, and the samples were taken at 24-hour intervals by shaking culture at 30 ℃ and 200 rpm to measure the OD 600 . Strains after knockout of the DAS gene were unable to grow in medium with methanol as the sole carbon source from the fermentation-verifying structure (fig. 2 (a)).
2. Compartmentalized positioned recombinant strain fermentation characterization
And verifying the positioning effect of the signal peptide PTS1, respectively inoculating the constructed characterization strains GS115-FGH-PTSI-GFP and GS115-FLD-PTS1-RFP to 100mL YPD liquid culture medium, adding 1% methanol in volume for induction at 30 ℃ and under 200 rpm, carrying out shaking culture for 24 hours, collecting thalli, and observing fluorescent expression at excitation wavelengths of 487nm and 554nm by using a fluorescent microscope. From the fluorescent pictures it can be seen that the signal peptide PTS1 is able to localize the protein into the peroxisome (FIG. 2 (b), FIG. 2 (c)).
3. Recombinant strain fermentation verification
Recombinant strains GS 115-DeltaFDH, original Pichia pastoris GS115, GS 115-DeltaFDH-rGly-DeltaDAS-FGH-FLD-TPS 1 are respectively inoculated into 5 mL YPD liquid culture medium, and are subjected to shaking culture at 30 ℃ and 200 rpm until OD600 is approximately equal to 5. The cultured bacterial solutions are all according to the initial OD 600 After centrifugation and resuspension of =0.2, the samples were inoculated into 100mL of fresh M9 liquid medium and 1% methanol was added thereto, and the samples were taken at 24-hour intervals by shaking culture at 30 ℃ and 200 rpm to measure the OD 600
From the growth curve, it can be seen that the reconstruction of the reductive glycine pathway in pichia pastoris can replace the original methanol metabolic pathway, so that the DAS gene knockout strain can normally utilize methanol, and the growth condition of the recombinant strain with the compartmentalization design is improved to a certain extent compared with that of the original strain (fig. 2 (d)).
Wherein, M9 medium (g/L): na (Na) 2 PO 4 ·7H 2 O 12.8、KH 2 PO 4 3.0、NaCl 0.5、NH 4 Cl 1、MgSO 4 ·7H 2 O 0.492、CaCl 2 ·6H 2 O 0.02191。
YPD Medium (g/L): peptone 2, yeast powder 1 and glucose 2.
4. Recombinant strain fermentation methanol consumption and formic acid accumulation
Recombinant strains GS 115-DeltaFDH, original Pichia pastoris GS115, GS 115-DeltaFDH-rGly-DeltaDAS-FGH-FLD-TPS 1 are respectively inoculated into 5 mL YPD liquid culture medium, and are subjected to shaking culture at 30 ℃ and 200 rpm until OD600 is approximately equal to 5. The cultured bacterial solutions are all according to the initial OD 600 After centrifugation and resuspension of =0.2, the culture medium was inoculated into 100mL of fresh M9 liquid medium, 1% methanol was added thereto, the culture was performed at 30 ℃ under 200 rpm with shaking, samples were taken every 24 hours, and the supernatant was collected by centrifugation and monitored for methanol consumption and formic acid accumulation during fermentation by HPLC high performance liquid chromatography. The recombinant strain and the original strain were the same in methanol consumption rate from the data, but the recombinant strain had a significant accumulation of formic acid (FIG. 2 (e), FIG. 2 (f)). The modified strain is proved to avoid the generation of CO by the differentiation of formic acid 2 The formate is preferably taken away to reconstitute the reductive glycine pathway into central metabolism.
EXAMPLE 4 recombinant Strain 13 C carbon dioxide labelling experiment
To further demonstrate the disruption of the reductive glycine pathway, one would proceed 13 C carbon dioxide labelling experiments. Recombinant strains the recombinant strains GS115- ΔFDH, pichia pastoris GS115, GS115- ΔFDH-rGly- ΔDAS-FGH-FLD-TPS1 were inoculated into 5 mL YPD liquid medium and cultured overnight at 30℃and 200 rpm. Then the cultured bacterial liquid is processed according to the initial OD 600 After centrifugation and resuspension =0.2, the cells were inoculated into 10mL of fresh M9 liquid medium and 1% by volume of methanol, 20Mm, was added 13 C-NaHCO 3 The culture was carried out at 30℃and 200 rpm for about 144 hours to carry out gas detection.
From FIG. 4 13 C- NaHCO 3 From the calibration results, CO 2 Can be immobilized by the reconstituted reductive glycine pathway, and further indicates successful opening of the pathway (fig. 4).
In conclusion, the invention provides a compartmentalization theoretical design of the reductive glycine pathway and the catabolism pathway by manually constructing in pichia pastoris for the first time, thereby improving the methanol and CO assimilation of the pichia pastoris 2 The efficiency is further improved, a foundation is laid for producing the compound by utilizing pichia pastoris in the future, and the method has profound significance.
In the foregoing, the protection scope of the present invention is not limited to the preferred embodiments of the present invention, and any simple changes or equivalent substitutions of the technical solutions that can be obviously obtained by those skilled in the art within the technical scope of the present invention disclosed in the present invention fall within the protection scope of the present invention.
Sequence listing
<110> university of Nanjing Industrial science
<120> construction of Pichia pastoris genetically engineered bacterium and application thereof in improving methanol assimilation rate and fixing carbon dioxide
<160> 18
<170> SIPOSequenceListing 1.0
<210> 1
<211> 56
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
tatttcgaaa cgaggaattg aaacgatgct ttcaagaatt ggatctagaa ataaag 56
<210> 2
<211> 44
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
acgtctcctg cttgctttaa cagagagaag ttcgtggcaa ataa 44
<210> 3
<211> 45
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
taaagcaagc aggagacgtg gaagaaaacc ccggtcctga aacga 45
<210> 4
<211> 46
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
agatgagttt ttgttctagt cactccggct tataaaattt gggggc 46
<210> 5
<211> 47
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
tatttcgaaa cgaggaattg aaacgatgtt aagaacccag ttctcca 47
<210> 6
<211> 45
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
tctcctgctt gctttaacag agagaagttc gtggcttgac tagca 45
<210> 7
<211> 48
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
tgttaaagca agcaggagac gtggaagaaa accccggtcc tgaaacga 48
<210> 8
<211> 47
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
atgatgatga tgatggtcga ttagctttcc tcctgcaaaa acttgac 47
<210> 9
<211> 981
<212> PRT
<213> amino acid sequence (Amino Acid Sequence)
<400> 9
Met Leu Ser Arg Ile Gly Ser Arg Ser Lys Ala Thr Ser Thr Val Arg
1 5 10 15
Arg Leu Ala Gly Asp Leu Leu Leu Gly Ser Arg Lys Leu His Ala Ser
20 25 30
Ala Val Phe Ser Gln Ala Gln Ile Leu Ser Gly Thr Lys Leu Ala Lys
35 40 45
Ser Ile Arg Ser Lys Val Phe Glu Glu Ile Asn Val Phe Lys Ala Thr
50 55 60
His Pro Glu Phe Gln Pro Ala Val Thr Ile Ile Gln Val Gly Asp Arg
65 70 75 80
Pro Asp Ser Ser Ala Tyr Val Arg Met Lys Leu Lys Ala Ala Ser Glu
85 90 95
Ser Gly Ile Ile Cys Asn Val Ile Lys Leu Pro Glu Asp Thr Ala Glu
100 105 110
Pro Thr Leu Ile Asn Arg Ile His Lys Leu Asn Asn Asp Asn Ser Val
115 120 125
His Gly Ile Leu Val Gln Leu Pro Leu Pro Ser His Ile Asp Glu Thr
130 135 140
His Ile Thr Asn Ser Val Ser Ile Leu Lys Asp Val Asp Gly Phe Asp
145 150 155 160
Arg Phe Asn Val Gly Glu Leu Ala Lys Lys Gly Gly Asn Pro Thr Phe
165 170 175
Leu Pro Cys Thr Pro Asn Gly Cys Met Lys Leu Leu Glu Ala Ser Gly
180 185 190
Val Glu Leu Ser Gly Lys Ser Ala Val Val Leu Gly Arg Ser Asp Ile
195 200 205
Val Gly Thr Pro Val Ala Gln Leu Leu Asn Lys Ala Asn Cys Thr Val
210 215 220
Thr Val Cys His Ser Arg Thr Pro Asn Ile Ala Glu Ile Val Lys Asn
225 230 235 240
Ser Asp Ile Val Val Ala Ala Ile Gly Lys Ala Asn Phe Val Lys Gly
245 250 255
Glu Trp Leu Lys Pro Gly Ala Val Val Ile Asp Val Gly Ile Asn Tyr
260 265 270
Val Pro Asp Pro Thr Lys Lys Ser Gly Gln Arg Leu Val Gly Asp Val
275 280 285
Glu Phe Glu Ser Ala Lys Glu Lys Ala Ser Val Ile Thr Pro Val Pro
290 295 300
Gly Gly Val Gly Pro Met Thr Val Ala Met Leu Val Ser Asn Ile Ala
305 310 315 320
His Ala Ala Lys Leu Gln Leu Glu Asn Asp Leu Lys Pro Ala Lys Ile
325 330 335
Tyr Ala Asn Pro Leu Glu Leu Lys Thr Pro Val Pro Ser Asp Ile Glu
340 345 350
Ile Ser Arg Ala Gln Glu Pro Arg Tyr Ile Lys Asp Ile Ala Thr Asp
355 360 365
Leu Gly Ile Lys Asp Lys Glu Leu Glu Leu Tyr Gly His Tyr Lys Ala
370 375 380
Lys Val Ser Leu Asp Val Tyr Asp Arg Leu Ala Lys Asn Arg Glu Asn
385 390 395 400
Gly Asn Tyr Val Leu Val Ala Gly Ile Thr Pro Thr Pro Leu Gly Glu
405 410 415
Gly Lys Ser Thr Thr Thr Met Gly Leu Val Gln Ala Leu Gly Ala His
420 425 430
Leu Asn Leu Ala Ala Val Ala Asn Val Arg Gln Pro Ser Met Gly Pro
435 440 445
Thr Phe Gly Val Lys Gly Gly Ala Ala Gly Gly Gly Tyr Ala Gln Val
450 455 460
Ile Pro Met Asp Glu Phe Asn Met His Leu Thr Gly Asp Ile His Ala
465 470 475 480
Ile Gly Ala Ala Asn Asn Leu Leu Ala Ala Ala Leu Asp Thr Arg Ile
485 490 495
Phe His Glu Thr Thr Gln Arg Asp Ala Ile Phe Tyr Lys Arg Leu Val
500 505 510
Pro Ala Lys Lys Gly Val Arg Lys Phe Thr Pro Ser Met Leu Lys Arg
515 520 525
Leu Glu Lys Leu Gly Ile Asn Lys Thr Glu Pro Asp Ser Leu Thr Pro
530 535 540
Glu Glu Ala Thr Lys Phe Ala Lys Leu Asn Ile Asp Pro Gln Thr Ile
545 550 555 560
Thr Val Lys Arg Val Leu Asp Val Asn Asp Arg Phe Val Arg Gln Val
565 570 575
Thr Ile Gly Glu Ala Pro Thr Glu Lys Gly His Ile Arg Lys Thr Gly
580 585 590
Phe Asp Ile Thr Val Ala Ser Glu Val Met Ala Ile Leu Ala Leu Ser
595 600 605
Lys Asp Leu Lys Asp Leu Arg Ser Arg Val Gly Ala Ile Val Val Ala
610 615 620
Ser Ser Tyr Glu Gly Val Pro Ile Thr Ala Glu Asp Leu Gly Val Ala
625 630 635 640
Gly Ala Leu Thr Ala Leu Leu Lys Asp Ala Val Lys Pro Asn Leu Met
645 650 655
Gln Thr Leu Glu Gly Thr Pro Val Phe Val His Ala Gly Pro Phe Ala
660 665 670
Asn Ile Ser Ile Gly Ala Ser Ser Val Ile Ala Asp Arg Val Ala Leu
675 680 685
Lys Leu Ile Gly Ala Ser Lys Ser Asp Val Val Ala Lys Ser Glu Lys
690 695 700
Gly Phe Val Val Thr Glu Ala Gly Phe Asp Phe Thr Met Gly Gly Glu
705 710 715 720
Arg Phe Tyr Asn Ile Lys Cys Arg Ala Ser Gly Leu Lys Pro Asn Thr
725 730 735
Val Val Leu Val Ala Thr Ser Arg Ala Leu Lys Leu His Gly Gly Ala
740 745 750
Pro Asp Val Lys Pro Gly Gln Ala Leu Pro Glu Glu Tyr Thr Thr Glu
755 760 765
Asn Val Glu Leu Val Arg Arg Gly Cys Ala Asn Leu Ala Lys Gln Ile
770 775 780
Ser Asn Ala Ser Gln Tyr Gly Ala Pro Val Val Val Ala Ile Asn Gln
785 790 795 800
Phe Glu Thr Asp Ser Pro Ala Glu Leu Ser Val Ile Arg Glu Glu Ala
805 810 815
Leu Lys Ala Gly Ala Phe Asp Ala Val Pro Ser Asn His Trp Ala Glu
820 825 830
Gly Gly Lys Gly Ala Val Glu Leu Ala Lys Ala Val Val Ser Ser Cys
835 840 845
Ala Ser Cys Pro Glu Pro Asn Ala Glu Lys Ala Glu Leu Tyr Ser Leu
850 855 860
Glu Asn Asn Thr Ile Glu Asp Arg Leu Asn Thr Ile Val Gln Lys Met
865 870 875 880
Tyr Asn Gly Asp Gly Ile Glu Leu Ser Glu Leu Ala Lys Glu Gln Ile
885 890 895
Ala Arg Tyr Glu Ala Gln Gly Phe Gly Asn Leu Pro Ile Cys Ile Ala
900 905 910
Lys Thr Gln Tyr Ser Leu Ser His Asp Pro Ser Leu Lys Asn Val Pro
915 920 925
Ala Gly Phe Thr Val Pro Ile Arg Glu Val Arg Leu Ser Ala Gly Ala
930 935 940
Gly Tyr Leu Ser Cys Leu Ala Ala Glu Ile Met Thr Ile Pro Gly Leu
945 950 955 960
Pro Thr His Pro Gly Tyr Leu Asn Val Glu Val Asn Asp Asp Gly Glu
965 970 975
Ile Glu Gly Leu Phe
980
<210> 10
<211> 391
<212> PRT
<213> amino acid sequence (Amino Acid Sequence)
<400> 10
Met Ile Arg Ser Cys Arg Arg Tyr Ser Thr Gly Val Glu Ala Leu Ile
1 5 10 15
Lys Thr Pro Leu Tyr Ser Val His Val Glu His Gly Ala Thr Leu Val
20 25 30
Pro Tyr Ala Asn Phe Ala Met Pro Val Leu Tyr Lys Gly Gln Ser His
35 40 45
Ile Glu Ser His Asn Trp Thr Arg Ser Lys Val Gly Ile Phe Asp Val
50 55 60
Ser His Met Leu Gln His Arg Val Lys Gly Asn Ser Ala Ala Glu Phe
65 70 75 80
Leu Gln Lys Ile Thr Pro Ser Asp Leu Lys Ala Leu Lys Pro Phe Thr
85 90 95
Ser Thr Leu Ser Val Leu Leu Asn Asp Lys Gly Gly Val Ile Asp Asp
100 105 110
Cys Ile Ile Thr Lys His Asp Glu Asn Glu Phe Tyr Ile Val Thr Asn
115 120 125
Ala Gly Cys Arg Asp Lys Asp Thr Ser Phe Ile Lys Glu Glu Ile Ser
130 135 140
Gln Phe Gly Asn Ala Ser His Glu Asn Phe Glu Gly Thr Leu Leu Ala
145 150 155 160
Ile Gln Gly Pro Gln Ala Ala Glu Thr Leu Gln Lys Phe Thr Asn Leu
165 170 175
Asp Leu Thr Lys Leu Tyr Phe Gly Asn Ser Ala Phe Ala Lys Leu Glu
180 185 190
Gly Phe Thr Ser Asp Val Ile His Ile Ala Arg Ser Gly Tyr Thr Gly
195 200 205
Glu Asp Gly Phe Glu Leu Ser Ile Pro Val Asp Ser Glu Gly Leu Glu
210 215 220
Phe Thr Lys Ala Leu Leu Glu Leu Glu Gln Val Lys Pro Ile Gly Leu
225 230 235 240
Ala Ala Arg Asp Ser Leu Arg Leu Glu Ala Gly Met Cys Leu Tyr Gly
245 250 255
His Glu Leu Asn Glu Gln Thr Thr Pro Val Glu Ser Ser Leu Asn Trp
260 265 270
Leu Ile Ala Lys Ser Arg Arg Thr Pro Lys Thr Ala Gly Phe Asn Gly
275 280 285
Ser Glu Asn Ile Leu Ser Gln Leu Glu Asn Pro Lys Ser Val Thr Phe
290 295 300
Lys Arg Val Gly Ile Gln Ser Lys Gly Pro Ser Pro Arg Glu Gly Asn
305 310 315 320
Lys Val Tyr Ser Phe Glu Glu Pro Asp Lys Gln Ile Gly Val Val Cys
325 330 335
Ser Gly Ser Pro Ser Pro Thr Leu Gly Gly Asn Val Gly Gln Ala Phe
340 345 350
Ile His Lys Pro His Gln Lys Ala Gly Thr Lys Ile Leu Ile Glu Ile
355 360 365
Arg Asn Lys Lys Arg Glu Ala His Val Ala Lys Leu Pro Phe Val Ala
370 375 380
Pro Lys Phe Tyr Lys Pro Glu
385 390
<210> 11
<211> 1015
<212> PRT
<213> amino acid sequence (Amino Acid Sequence)
<400> 11
Met Leu Arg Thr Gln Leu Ser Lys Ala Leu Leu Lys Ser His Ser Val
1 5 10 15
Lys Ala Trp Ala Arg Val Gly Thr Ala Thr Thr Ser Arg Phe Val Ser
20 25 30
Asp Thr Thr Ser Ala Thr Phe Arg Ser Ile Tyr Glu Lys Gly Ser Ser
35 40 45
Thr Pro Ser Pro Tyr Asp Gly Thr Asp Ser Phe Pro Arg Arg His Leu
50 55 60
Gly Pro Thr Pro Asn Asn Val Asp Glu Met Leu Gln Asp Leu Lys Glu
65 70 75 80
Ser Asp Leu Asp Ser Phe Ile Ala Lys Val Val Pro Asp Asn Val Leu
85 90 95
Ile Arg Arg Ser Leu Lys Val Glu Pro Leu Lys Gly Phe Thr Glu Ser
100 105 110
Glu Met Leu Ala Glu Leu Ala Arg Ile Ala Glu Lys Asn Asp Leu Val
115 120 125
Lys Pro Leu Ile Gly Lys Gly Phe Tyr Gly Thr Ile Ile Pro Pro Val
130 135 140
Ile Leu Arg Asn Leu Leu Glu Asn Pro Gly Trp Tyr Thr Ser Tyr Thr
145 150 155 160
Pro Tyr Gln Pro Glu Val Ser Gln Gly Arg Leu Glu Ser Leu Leu Asn
165 170 175
Phe Gln Thr Val Ile Ser Asp Leu Thr Gly Leu Pro Val Ala Asn Ala
180 185 190
Ser Leu Leu Asp Glu Ser Ser Ala Ala Ala Glu Ala Met Ile Leu Ser
195 200 205
Phe Thr Ser Leu Lys Ser Lys Lys Pro Lys Tyr Phe Val Asp Ser Asn
210 215 220
Ile His Glu Gln Thr Leu Ala Val Leu Lys Ser Arg Ala His Thr Leu
225 230 235 240
Ser Ile Glu Val Val Val Ala Asp Leu Thr Thr Asp Glu Gly Phe Ala
245 250 255
Ala Leu Gln Glu Asn Lys Asp Gln Leu Cys Gly Ala Met Val Gln Tyr
260 265 270
Pro Ala Thr Asp Gly Ser Ile Glu Thr Phe Lys Ala Tyr Ser Arg Ile
275 280 285
Ala Glu Leu Val His Ser Val Lys Gly Leu Tyr Ala Val Ala Ser Asp
290 295 300
Leu Met Ala Leu Thr Leu Leu His Ala Pro Ser Lys Phe Gly Ala Asp
305 310 315 320
Ile Val Phe Gly Ser Ser Gln Arg Phe Gly Val Pro Leu Gly Tyr Gly
325 330 335
Gly Pro His Ala Ala Phe Phe Ser Val Val Glu Ser Leu Gln Arg Lys
340 345 350
Ile Pro Gly Arg Ile Val Gly Val Ser Lys Asp Arg Leu Gly Asn Asn
355 360 365
Ala Leu Arg Leu Ala Leu Gln Thr Arg Glu Gln His Ile Lys Arg Glu
370 375 380
Arg Ala Thr Ser Asn Ile Cys Thr Ala Gln Ala Leu Leu Ala Asn Ile
385 390 395 400
Ala Ala Asn Tyr Val Val Tyr His Gly Ile Glu Gly Leu Arg Asn Ile
405 410 415
Ser Lys Arg Ile His Gly Phe Thr Thr Leu Leu Ala Asn Ser Ile Asn
420 425 430
Glu Ser Ser Ser His Lys Val Leu Asn Glu Lys Trp Phe Asp Thr Leu
435 440 445
Ser Val Asp Val Gly Ser Ala Asp Glu Phe Ile Ala Lys Ala Leu Ser
450 455 460
Lys Asn Phe Asn Val Phe Arg Val Asn Asn Ser Thr Ile Gln Leu Ser
465 470 475 480
Leu Asp Glu Thr Val Thr Lys Asn Glu Leu Thr Thr Leu Ile Ser Leu
485 490 495
Phe Thr Gly Ser Ser Glu Val Asn Leu Pro Glu Thr Leu Pro Ser Phe
500 505 510
Tyr Glu Glu Trp Thr Arg Gln Asp Asp Ile Leu Thr Asn Glu Val Phe
515 520 525
Arg Thr His Arg Ser Glu Thr Ser Met Leu Arg Tyr Leu Thr His Leu
530 535 540
Gln Lys Lys Asp Ile Ser Leu Ala Asp Ser Met Ile Ser Leu Gly Ser
545 550 555 560
Cys Thr Met Lys Leu Asn Ala Thr Val Glu Met Met Pro Ile Ser Trp
565 570 575
Pro Lys Phe Ala Asn Ile His Pro Phe Ala Pro Lys Asp Gln Val Lys
580 585 590
Gly Tyr Thr Glu Leu Ile Val Glu Leu Glu Lys Asp Leu Ala Asp Ile
595 600 605
Thr Gly Phe His Ser Thr Thr Leu Gln Pro Asn Ser Gly Ala Gln Gly
610 615 620
Glu Tyr Thr Gly Leu Ser Val Ile Ala Lys Tyr Phe Glu Ser Lys Gly
625 630 635 640
Glu Ala His Arg Asn Ile Val Leu Ile Pro Val Ser Ala His Gly Thr
645 650 655
Asn Pro Ala Ser Ala Ala Met Ala Gly Leu Lys Val Val Pro Ile Lys
660 665 670
Cys Leu Lys Asp Gly Ser Leu Asp Leu Gln Asp Leu Glu Ser Lys Ala
675 680 685
Ser Lys His Ala Lys Asn Leu Ala Ala Met Met Val Thr Tyr Pro Ser
690 695 700
Thr Tyr Gly Leu Phe Glu Pro Gly Ile Ile Asp Ala Ile Lys Ile Ile
705 710 715 720
His Asn His Gly Gly Gln Val Tyr Leu Asp Gly Ala Asn Met Asn Ala
725 730 735
Gln Val Gly Leu Thr Ser Pro Gly Asp Leu Gly Ala Asp Val Cys His
740 745 750
Leu Asn Leu His Lys Thr Phe Ala Ile Pro His Gly Gly Gly Gly Pro
755 760 765
Gly Val Gly Pro Ile Cys Val Lys Glu His Leu Thr Pro Phe Leu Pro
770 775 780
Ser His Pro Ile Ile Ala Thr Thr Asn Gln Thr Glu Gln Ser Ile Asn
785 790 795 800
Pro Val Val Ala Ala Pro Phe Gly Ser Ala Ser Ile Leu Pro Ile Ser
805 810 815
Tyr Ala Tyr Ile Lys Met Met Gly Gly Ser Asn Leu Gln Tyr Ser Ser
820 825 830
Ile Ile Ala Ile Leu Asn Ala Asn Tyr Met Val Ala Lys Leu Lys Asn
835 840 845
His Phe Glu Ile Leu Phe Thr Gly Gly Asp Ala Lys Tyr Cys Gly His
850 855 860
Glu Phe Ile Ile Asp Leu Arg Pro Phe Lys Lys Phe Gly Ile Glu Ala
865 870 875 880
Ile Asp Val Ala Lys Arg Leu Gln Asp Tyr Gly Phe His Ala Pro Thr
885 890 895
Met Ser Phe Pro Ile Pro Gly Thr Leu Met Val Glu Pro Thr Glu Ser
900 905 910
Glu Tyr Lys Glu Glu Leu Asp Arg Phe Ile Asp Ser Met Ile Ser Ile
915 920 925
Arg Glu Glu Ile Arg Lys Val Glu Asn Gly Glu Thr Asp Gly Ala Ile
930 935 940
Leu His Asn Ser Pro His Asn Leu Lys Asp Ile Ile Ser Thr Ser Asp
945 950 955 960
Ala Glu Trp Ser Gln Arg Gly Tyr Thr Arg Glu Glu Ala Ala Tyr Pro
965 970 975
Leu Pro Phe Leu Lys Glu Gln Lys Thr Trp Pro Thr Val Ser Arg Val
980 985 990
Asp Asp Thr Tyr Gly Asp Met Asn Leu Leu Cys Thr Cys Pro Ser Val
995 1000 1005
Glu Glu Val Ala Ala Ser Gln
1010 1015
<210> 12
<211> 1015
<212> PRT
<213> amino acid sequence (Amino Acid Sequence)
<400> 12
Met Leu Arg Thr Gln Leu Ser Lys Ala Leu Leu Lys Ser His Ser Val
1 5 10 15
Lys Ala Trp Ala Arg Val Gly Thr Ala Thr Thr Ser Arg Phe Val Ser
20 25 30
Asp Thr Thr Ser Ala Thr Phe Arg Ser Ile Tyr Glu Lys Gly Ser Ser
35 40 45
Thr Pro Ser Pro Tyr Asp Gly Thr Asp Ser Phe Pro Arg Arg His Leu
50 55 60
Gly Pro Thr Pro Asn Asn Val Asp Glu Met Leu Gln Asp Leu Lys Glu
65 70 75 80
Ser Asp Leu Asp Ser Phe Ile Ala Lys Val Val Pro Asp Asn Val Leu
85 90 95
Ile Arg Arg Ser Leu Lys Val Glu Pro Leu Lys Gly Phe Thr Glu Ser
100 105 110
Glu Met Leu Ala Glu Leu Ala Arg Ile Ala Glu Lys Asn Asp Leu Val
115 120 125
Lys Pro Leu Ile Gly Lys Gly Phe Tyr Gly Thr Ile Ile Pro Pro Val
130 135 140
Ile Leu Arg Asn Leu Leu Glu Asn Pro Gly Trp Tyr Thr Ser Tyr Thr
145 150 155 160
Pro Tyr Gln Pro Glu Val Ser Gln Gly Arg Leu Glu Ser Leu Leu Asn
165 170 175
Phe Gln Thr Val Ile Ser Asp Leu Thr Gly Leu Pro Val Ala Asn Ala
180 185 190
Ser Leu Leu Asp Glu Ser Ser Ala Ala Ala Glu Ala Met Ile Leu Ser
195 200 205
Phe Thr Ser Leu Lys Ser Lys Lys Pro Lys Tyr Phe Val Asp Ser Asn
210 215 220
Ile His Glu Gln Thr Leu Ala Val Leu Lys Ser Arg Ala His Thr Leu
225 230 235 240
Ser Ile Glu Val Val Val Ala Asp Leu Thr Thr Asp Glu Gly Phe Ala
245 250 255
Ala Leu Gln Glu Asn Lys Asp Gln Leu Cys Gly Ala Met Val Gln Tyr
260 265 270
Pro Ala Thr Asp Gly Ser Ile Glu Thr Phe Lys Ala Tyr Ser Arg Ile
275 280 285
Ala Glu Leu Val His Ser Val Lys Gly Leu Tyr Ala Val Ala Ser Asp
290 295 300
Leu Met Ala Leu Thr Leu Leu His Ala Pro Ser Lys Phe Gly Ala Asp
305 310 315 320
Ile Val Phe Gly Ser Ser Gln Arg Phe Gly Val Pro Leu Gly Tyr Gly
325 330 335
Gly Pro His Ala Ala Phe Phe Ser Val Val Glu Ser Leu Gln Arg Lys
340 345 350
Ile Pro Gly Arg Ile Val Gly Val Ser Lys Asp Arg Leu Gly Asn Asn
355 360 365
Ala Leu Arg Leu Ala Leu Gln Thr Arg Glu Gln His Ile Lys Arg Glu
370 375 380
Arg Ala Thr Ser Asn Ile Cys Thr Ala Gln Ala Leu Leu Ala Asn Ile
385 390 395 400
Ala Ala Asn Tyr Val Val Tyr His Gly Ile Glu Gly Leu Arg Asn Ile
405 410 415
Ser Lys Arg Ile His Gly Phe Thr Thr Leu Leu Ala Asn Ser Ile Asn
420 425 430
Glu Ser Ser Ser His Lys Val Leu Asn Glu Lys Trp Phe Asp Thr Leu
435 440 445
Ser Val Asp Val Gly Ser Ala Asp Glu Phe Ile Ala Lys Ala Leu Ser
450 455 460
Lys Asn Phe Asn Val Phe Arg Val Asn Asn Ser Thr Ile Gln Leu Ser
465 470 475 480
Leu Asp Glu Thr Val Thr Lys Asn Glu Leu Thr Thr Leu Ile Ser Leu
485 490 495
Phe Thr Gly Ser Ser Glu Val Asn Leu Pro Glu Thr Leu Pro Ser Phe
500 505 510
Tyr Glu Glu Trp Thr Arg Gln Asp Asp Ile Leu Thr Asn Glu Val Phe
515 520 525
Arg Thr His Arg Ser Glu Thr Ser Met Leu Arg Tyr Leu Thr His Leu
530 535 540
Gln Lys Lys Asp Ile Ser Leu Ala Asp Ser Met Ile Ser Leu Gly Ser
545 550 555 560
Cys Thr Met Lys Leu Asn Ala Thr Val Glu Met Met Pro Ile Ser Trp
565 570 575
Pro Lys Phe Ala Asn Ile His Pro Phe Ala Pro Lys Asp Gln Val Lys
580 585 590
Gly Tyr Thr Glu Leu Ile Val Glu Leu Glu Lys Asp Leu Ala Asp Ile
595 600 605
Thr Gly Phe His Ser Thr Thr Leu Gln Pro Asn Ser Gly Ala Gln Gly
610 615 620
Glu Tyr Thr Gly Leu Ser Val Ile Ala Lys Tyr Phe Glu Ser Lys Gly
625 630 635 640
Glu Ala His Arg Asn Ile Val Leu Ile Pro Val Ser Ala His Gly Thr
645 650 655
Asn Pro Ala Ser Ala Ala Met Ala Gly Leu Lys Val Val Pro Ile Lys
660 665 670
Cys Leu Lys Asp Gly Ser Leu Asp Leu Gln Asp Leu Glu Ser Lys Ala
675 680 685
Ser Lys His Ala Lys Asn Leu Ala Ala Met Met Val Thr Tyr Pro Ser
690 695 700
Thr Tyr Gly Leu Phe Glu Pro Gly Ile Ile Asp Ala Ile Lys Ile Ile
705 710 715 720
His Asn His Gly Gly Gln Val Tyr Leu Asp Gly Ala Asn Met Asn Ala
725 730 735
Gln Val Gly Leu Thr Ser Pro Gly Asp Leu Gly Ala Asp Val Cys His
740 745 750
Leu Asn Leu His Lys Thr Phe Ala Ile Pro His Gly Gly Gly Gly Pro
755 760 765
Gly Val Gly Pro Ile Cys Val Lys Glu His Leu Thr Pro Phe Leu Pro
770 775 780
Ser His Pro Ile Ile Ala Thr Thr Asn Gln Thr Glu Gln Ser Ile Asn
785 790 795 800
Pro Val Val Ala Ala Pro Phe Gly Ser Ala Ser Ile Leu Pro Ile Ser
805 810 815
Tyr Ala Tyr Ile Lys Met Met Gly Gly Ser Asn Leu Gln Tyr Ser Ser
820 825 830
Ile Ile Ala Ile Leu Asn Ala Asn Tyr Met Val Ala Lys Leu Lys Asn
835 840 845
His Phe Glu Ile Leu Phe Thr Gly Gly Asp Ala Lys Tyr Cys Gly His
850 855 860
Glu Phe Ile Ile Asp Leu Arg Pro Phe Lys Lys Phe Gly Ile Glu Ala
865 870 875 880
Ile Asp Val Ala Lys Arg Leu Gln Asp Tyr Gly Phe His Ala Pro Thr
885 890 895
Met Ser Phe Pro Ile Pro Gly Thr Leu Met Val Glu Pro Thr Glu Ser
900 905 910
Glu Tyr Lys Glu Glu Leu Asp Arg Phe Ile Asp Ser Met Ile Ser Ile
915 920 925
Arg Glu Glu Ile Arg Lys Val Glu Asn Gly Glu Thr Asp Gly Ala Ile
930 935 940
Leu His Asn Ser Pro His Asn Leu Lys Asp Ile Ile Ser Thr Ser Asp
945 950 955 960
Ala Glu Trp Ser Gln Arg Gly Tyr Thr Arg Glu Glu Ala Ala Tyr Pro
965 970 975
Leu Pro Phe Leu Lys Glu Gln Lys Thr Trp Pro Thr Val Ser Arg Val
980 985 990
Asp Asp Thr Tyr Gly Asp Met Asn Leu Leu Cys Thr Cys Pro Ser Val
995 1000 1005
Glu Glu Val Ala Ala Ser Gln
1010 1015
<210> 13
<211> 299
<212> PRT
<213> amino acid sequence (Amino Acid Sequence)
<400> 13
Met Ser Ser Ile Thr Thr Ser Ile Phe Lys Val Thr Ala Glu Ile Gln
1 5 10 15
Ser Phe Gly Gly Lys Leu Val Lys Leu Gln His Lys Ser Asp Glu Thr
20 25 30
Lys Thr Asp Met Asp Val Asn Val Tyr Leu Pro Ala Gln Phe Phe Ala
35 40 45
Asn Gly Ala Lys Gly Lys Ser Leu Pro Val Leu Leu Tyr Leu Ser Gly
50 55 60
Leu Thr Cys Thr Pro Asn Asn Ala Ser Glu Lys Ala Phe Trp Gln Pro
65 70 75 80
Tyr Ala Asn Lys Tyr Gly Phe Ala Val Val Phe Pro Asp Thr Ser Pro
85 90 95
Arg Gly Leu Asn Ile Glu Gly Glu His Asp Ser Tyr Asp Phe Gly Ser
100 105 110
Gly Ala Gly Phe Tyr Val Asp Ala Thr Thr Glu Lys Trp Lys Asp Asn
115 120 125
Tyr Arg Met Tyr Ser Tyr Val Asn Ser Glu Leu Leu Pro Lys Leu Gln
130 135 140
Ala Asp Phe Pro Ile Leu Asn Phe Asp Asn Ile Ser Ile Thr Gly His
145 150 155 160
Ser Met Gly Gly Tyr Gly Ala Leu Gln Leu Phe Leu Arg Asn Pro Gly
165 170 175
Lys Phe Lys Ser Val Ser Ala Phe Ser Pro Ile Ser Asn Pro Thr Lys
180 185 190
Ala Pro Trp Gly Glu Lys Cys Phe Ser Gly Tyr Leu Gly Gln Asp Lys
195 200 205
Ser Thr Trp Thr Gln Tyr Asp Pro Thr Glu Leu Ile Gly Lys Tyr Gln
210 215 220
Gly Pro Ser Asp Ser Ser Ile Leu Ile His Val Gly Lys Ser Asp Ser
225 230 235 240
Phe Tyr Phe Lys Asp His Gln Leu Leu Pro Glu Asn Phe Leu Lys Ala
245 250 255
Ser Glu Asn Ser Val Phe Lys Gly Lys Val Asp Leu Asn Leu Val Asp
260 265 270
Gly Tyr Asp His Ser Tyr Tyr Phe Ile Ser Ser Phe Thr Asp Val His
275 280 285
Ala Ala His His Ala Lys Tyr Leu Gly Leu Asn
290 295
<210> 14
<211> 379
<212> PRT
<213> amino acid sequence (Amino Acid Sequence)
<400> 14
Met Ser Thr Glu Gly Gln Ile Ile Lys Cys Lys Ala Ala Val Ala Trp
1 5 10 15
Glu Ala Gly Lys Asp Leu Ser Ile Glu Glu Ile Glu Val Leu Pro Pro
20 25 30
Arg Ala His Glu Val Arg Val Lys Val Glu Phe Thr Gly Val Cys His
35 40 45
Thr Asp Ala Tyr Thr Leu Ser Gly Ala Asp Ala Glu Gly Ser Phe Pro
50 55 60
Val Val Phe Gly His Glu Gly Ala Gly Val Val Glu Ser Val Gly Glu
65 70 75 80
Gly Val Glu Ser Val Lys Val Gly Asp Ser Val Val Leu Leu Tyr Thr
85 90 95
Pro Glu Cys Arg Glu Cys Lys Phe Cys Leu Ser Gly Lys Thr Asn Leu
100 105 110
Cys Gly Lys Ile Arg Ala Thr Gln Gly Lys Gly Leu Leu Pro Asp Gly
115 120 125
Thr Ser Arg Phe Arg Cys Lys Gly Lys Asp Leu Phe His Tyr Met Gly
130 135 140
Cys Ser Ser Phe Ser Gln Tyr Thr Val Val Ala Asp Ile Ser Val Val
145 150 155 160
Lys Val Gln Asp Glu Ala Pro Lys Asp Lys Thr Cys Leu Leu Gly Cys
165 170 175
Gly Val Thr Thr Gly Tyr Gly Ala Ala Ile Asn Thr Ala Lys Ile Ser
180 185 190
Lys Gly Asp Lys Ile Gly Val Phe Gly Ala Gly Cys Ile Gly Leu Ser
195 200 205
Val Ile Gln Gly Ala Val Ser Lys Gly Ala Ser Glu Ile Ile Val Ile
210 215 220
Asp Ile Asn Asp Ser Lys Lys Ala Trp Ala Asp Gln Phe Gly Ala Thr
225 230 235 240
Lys Phe Val Asn Pro Thr Thr Leu Pro Glu Gly Thr Asn Ile Val Asp
245 250 255
Tyr Leu Ile Asp Ile Thr Asp Gly Gly Phe Asp Tyr Thr Phe Asp Cys
260 265 270
Thr Gly Asn Val Gln Val Met Arg Asn Ala Leu Glu Ser Cys His Lys
275 280 285
Gly Trp Gly Glu Ser Ile Ile Ile Gly Val Ala Ala Ala Gly Lys Glu
290 295 300
Ile Ser Thr Arg Pro Phe Gln Leu Val Thr Gly Arg Val Trp Arg Gly
305 310 315 320
Cys Ala Phe Gly Gly Ile Lys Gly Arg Thr Gln Met Pro Ser Leu Val
325 330 335
Gln Asp Tyr Leu Asp Gly Lys Ile Lys Val Asp Glu Phe Ile Thr His
340 345 350
Arg His Asp Leu Asp Asn Ile Asn Lys Ala Phe His Asp Met His Ala
355 360 365
Gly Asn Cys Ile Arg Ala Val Ile Thr Met His
370 375
<210> 15
<211> 58
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
caactaatta ttcgaaggat ccgaaacgat gtcatcaatt actacttcaa tcttcaag 58
<210> 16
<211> 75
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
cacgtctcct gcttgcttta acagagagaa gttcgtggcc aacttagagt ttaaccccaa 60
atactttgca tggtg 75
<210> 17
<211> 76
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 17
tgttaaagca agcaggagac gtggaagaaa accccggtcc tgaaacgatg tctaccgaag 60
gtcaagtaag ttcaat 76
<210> 18
<211> 55
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 18
aaggcgaatt aattcgcggc cgcttacaac ttagagtgca tagtaatcac agcac 55

Claims (3)

1. The construction method of the Pichia pastoris genetic engineering bacteria is characterized by comprising the following steps:
step 1, respectively designing primers corresponding to a reductive glycine pathway related gene MIS1, a reductive glycine pathway related gene GCV2 and a reductive glycine pathway related gene GCV3, using pichia pastoris GS115 genome as a template, and obtaining MIS1, GCV2 and GCV3 gene fragments corresponding to the primers respectively by PCR amplification, wherein the nucleic acid sequence of an upstream primer MIS1-F used by MIS1 is shown as SEQ ID No. 1, and the nucleic acid sequence of a downstream primer MIS1-R is shown as SEQ ID No. 2; the nucleic acid sequence of the upstream primer GCV1-F used by the GCV1 is shown as SEQ ID No. 3, the nucleic acid sequence of the downstream primer GCV1-R is shown as SEQ ID No. 4, the nucleic acid sequence of the upstream primer GVC2-F used by the GCV2 is shown as SEQ ID No. 5, the nucleic acid sequence of the downstream primer GVC 2-R is shown as SEQ ID No. 6, the nucleic acid sequence of the upstream primer used by the GCV3 is shown as SEQ ID No. 7, and the nucleic acid sequence of the downstream primer GCV3-R is shown as SEQ ID No. 8;
step 2, knocking out FDH genes in a dissimilation pathway in Pichia pastoris GS115 by using a CRISPR-Cas9 gene knockout technology to obtain a recombinant strain GS 115-delta FDH;
step 3, constructing recombinant plasmids pGAP-MIS1-P2A-GCV1 and pGAP-GCV2-P2A-GCV3, and a knockout plasmid pET28a-His for knocking out DAS genes, wherein the recombinant plasmid pGAP-MIS1-P2A-GCV1 is a recombinant plasmid containing the MIS1 gene fragment and the GCV1 gene fragment amplified in the step 1, the recombinant plasmid pGAP-GCV2-P2A-GCV3 is a recombinant plasmid containing the GCV2 gene fragment and the GCV3 gene fragment amplified in the step 1, the amino acid sequence coded by the MIS1 gene fragment is shown as SEQ ID No. 9, and the amino acid sequence coded by the GCV1 gene fragment is shown as SEQ ID No. 10; the amino acid sequence of the GCV2 gene fragment is shown as SEQ ID No. 11, and the amino acid sequence of the GCV3 gene fragment is shown as SEQ ID No. 12;
step 4, recombinant plasmids pGAP-MIS1-P2A-GCV1 and pGAP-GCV2-P2A-GCV3 are introduced into pichia pastoris GS 115-delta FDH, and double-crossover homologous recombination is carried out by using knockout plasmid pET28a-His to knockout DAS genes in pichia pastoris, so that the original methanol assimilation way is replaced by a reductive glycine way;
step 5, constructing a recombinant plasmid pIC9K-FLD-P2A-FGH-PTS1, wherein the recombinant plasmid pIC9K-FLD-P2A-FGH-PTS1 comprises FLD gene fragments, FGH gene fragments and PTS1 signal peptide, carrying out PCR amplification on Pichia pastoris GS115 methanol catabolism pathway FLD and FGH genes by using specific primers, and adding PTS1 signal peptide at the sequence C end to position the catabolism pathway in a peroxisome, wherein the amino acid sequence coded by the FGH gene fragments is shown as SEQ ID No. 13, and the amino acid sequence coded by the FLD gene fragments is shown as SEQ ID No. 14;
and 6, introducing the recombinant plasmid pIC9K-FLD-P2A-FGH-PTS1 into the recombinant pichia pastoris constructed in the step 4, and realizing compartmentalization positioning expression of a pichia pastoris methanol catabolism pathway to obtain the pichia pastoris genetic engineering bacteria.
2. The method for constructing a genetically engineered pichia pastoris of claim 1, wherein the reaction conditions for the PCR in step 1 are: 95 ℃ for 2 min, 95 ℃ for 20 s,55 ℃ for 20 s,72 ℃ for 10 s, and 30 cycles in total; and at 72℃for 5 min.
3. The application of the Pichia pastoris engineering bacteria constructed by the construction method of claim 1 in improving methanol assimilation rate of Pichia pastoris and fixing carbon dioxide.
CN202210181077.8A 2022-02-26 2022-02-26 Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide Active CN114634946B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210181077.8A CN114634946B (en) 2022-02-26 2022-02-26 Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210181077.8A CN114634946B (en) 2022-02-26 2022-02-26 Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide

Publications (2)

Publication Number Publication Date
CN114634946A CN114634946A (en) 2022-06-17
CN114634946B true CN114634946B (en) 2023-12-22

Family

ID=81947066

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210181077.8A Active CN114634946B (en) 2022-02-26 2022-02-26 Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide

Country Status (1)

Country Link
CN (1) CN114634946B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730499B1 (en) * 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
CN101104859A (en) * 2007-04-28 2008-01-16 华东理工大学 Non-methanol evoked pichia pastoris protein expression system and use thereof
CN112813129A (en) * 2021-02-05 2021-05-18 江南大学 Method for increasing 7-dehydrocholesterol yield in yeast by compartmentalization

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730499B1 (en) * 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
CN101104859A (en) * 2007-04-28 2008-01-16 华东理工大学 Non-methanol evoked pichia pastoris protein expression system and use thereof
CN112813129A (en) * 2021-02-05 2021-05-18 江南大学 Method for increasing 7-dehydrocholesterol yield in yeast by compartmentalization

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Assimilation of formic acid and CO2 by engineered Escherichia coli equipped with reconstructed one-carbon assimilation pathways;Junho Bang等;PNAS;第115卷(第40期);E9271-9279页 *
Regulation of methanol utilisation pathway gene in yeasts;Franz S Hartner等;Microbial Cell Factories;第5卷;第1-21页 *
甲醇生物转化的机遇与挑战;高教琪等;合成生物学;第1卷(第2期);第158-173页 *

Also Published As

Publication number Publication date
CN114634946A (en) 2022-06-17

Similar Documents

Publication Publication Date Title
CN112194720A (en) Recombinant human III-type collagen and production method thereof
CN111705030B (en) Escherichia coli genetic engineering bacterium capable of producing L-homoserine with high yield, construction method and strain
CN107201374B (en) Construction method and application of optical pure meso-2, 3-butanediol high-yield engineering strain
CN111748535B (en) Alanine dehydrogenase mutant and application thereof in fermentation production of L-alanine
CN113564090B (en) Construction method for recombinant bacteria producing tetrahydropyrimidine and application thereof
CN106754979B (en) Gene for regulating and controlling long-chain fatty acid transport of candida tropicalis and application of gene
CN114634946B (en) Construction of Pichia pastoris genetically engineered bacteria and application of pichia pastoris genetically engineered bacteria in improving methanol assimilation rate and fixing carbon dioxide
CN111295446B (en) Mutant microorganism for producing succinic acid by introducing highly active malate dehydrogenase and method for producing succinic acid using the same
CN113249240B (en) Saccharomyces cerevisiae for high yield of hydroxytyrosol and construction method thereof
CN114525215B (en) Recombinant strain for producing terpenoid, construction method thereof, method for producing terpenoid through fermentation and application of recombinant strain
CN114410562B (en) Klebsiella engineering bacterium and application thereof in ethanol production
CN116676243A (en) Construction method and application of recombinant escherichia coli producing 2&#39; -fucosyllactose
CN112522222B (en) Novel tryptophan hydroxylase mutant and application thereof
CN114806913A (en) High-yield succinic acid yeast engineering strain with mitochondrion positioning reduction TCA (trichloroacetic acid) approach as well as construction method and application thereof
KR101551533B1 (en) Recombinant microorganism having enhanced butanediol producing ability and method for producing butanediol using the same
KR20230145054A (en) Recombinant strain of the engineered gene BBD29_14900 and its construction method and application
CN113583925A (en) Method for preparing patchouli alcohol by fermenting metabolic engineering escherichia coli
CN112852847A (en) Recombinant saccharomyces cerevisiae strain and construction method and application thereof
CN112062822B (en) Carbon catabolism regulatory protein CcpA mutant I42A
CN116121092B (en) Recombinant saccharomyces cerevisiae with enhanced multiple stress resistance, construction method and application thereof
CN107475269B (en) acyl-CoA thioesterase gene of candida tropicalis and application thereof
CN112062821B (en) Carbon catabolism regulatory protein CcpA mutant K31A
CN114250237B (en) Tyrosine phenol lyase mutant, engineering bacterium and application thereof in catalytic synthesis of levodopa
WO2024140379A1 (en) Enzyme, strain for producing salidroside, and production method
CN107267405B (en) Method for improving tolerance of torulopsis glabrata acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant